Taking your OCT outside of the posterior pole
Incorporating peripheral OCTs into your practice provides valuable insights which may alter your clinical diagnosis.
Refractive surgery real talk on SMILE, LASIK, PRK, RLE, and ICL
Atropine vs spectacles: Which move will be more powerful in the game of myopia management?
An official approval by the FDA in the United States can boost adoption rate of atropine and antimyopia glasses, which will change the landscape of myopia management.
What do we lose if we do not value residencies?
Diane Russo, OD, MPH, MBA, FAAO, Dipl AAO PH, and Nicole Quinn, OD, FAAO, highlight the continued importance of residencies in optometric practices.
Boehringer Ingelheim kicks off dual phase 2 clinical studies for geographic atrophy candidates
Boehringer Ingelheim announced that the phase 2 clinical studies will investigate a potential first-in-class oral compound and a highly specific antibody fragment for geographic atrophy.
